X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with AANJANEYA LIFECARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs DR. DATSONS LABS - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA DR. DATSONS LABS PLETHICO PHARMA/
DR. DATSONS LABS
 
P/E (TTM) x -1.1 -10.9 - View Chart
P/BV x 0.0 0.2 10.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 PLETHICO PHARMA   DR. DATSONS LABS
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
DR. DATSONS LABS
Mar-14
PLETHICO PHARMA/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs395126 314.4%   
Low Rs3131 101.3%   
Sales per share (Unadj.) Rs604.4133.0 454.5%  
Earnings per share (Unadj.) Rs32.50.2 21,422.5%  
Cash flow per share (Unadj.) Rs51.36.6 776.8%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs473.6128.8 367.7%  
Shares outstanding (eoy) m34.0831.66 107.6%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x0.40.6 59.9%   
Avg P/E ratio x6.6516.1 1.3%  
P/CF ratio (eoy) x4.211.8 35.1%  
Price / Book Value ratio x0.50.6 74.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m7,2622,477 293.1%   
No. of employees `000NANA-   
Total wages/salary Rs m1,59656 2,850.0%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m20,5984,211 489.2%  
Other income Rs m38679 490.9%   
Total revenues Rs m20,9844,289 489.2%   
Gross profit Rs m2,818569 495.5%  
Depreciation Rs m642204 314.2%   
Interest Rs m1,593430 370.3%   
Profit before tax Rs m96913 7,626.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1386 -2,268.5%   
Profit after tax Rs m1,1075 23,060.0%  
Gross profit margin %13.713.5 101.3%  
Effective tax rate %-14.348.0 -29.7%   
Net profit margin %5.40.1 4,713.8%  
BALANCE SHEET DATA
Current assets Rs m18,8776,852 275.5%   
Current liabilities Rs m11,8966,711 177.3%   
Net working cap to sales %33.93.3 1,012.0%  
Current ratio x1.61.0 155.4%  
Inventory Days Days36161 22.3%  
Debtors Days Days198318 62.1%  
Net fixed assets Rs m9,8613,673 268.5%   
Share capital Rs m341317 107.6%   
"Free" reserves Rs m12,3313,761 327.9%   
Net worth Rs m16,1394,078 395.8%   
Long term debt Rs m4,7061,671 281.6%   
Total assets Rs m33,14612,633 262.4%  
Interest coverage x1.61.0 156.2%   
Debt to equity ratio x0.30.4 71.2%  
Sales to assets ratio x0.60.3 186.4%   
Return on assets %8.13.4 236.6%  
Return on equity %6.90.1 5,826.2%  
Return on capital %12.37.7 160.2%  
Exports to sales %21.422.9 93.4%   
Imports to sales %15.214.3 106.5%   
Exports (fob) Rs m4,402964 456.7%   
Imports (cif) Rs m3,136602 521.0%   
Fx inflow Rs m4,402964 456.7%   
Fx outflow Rs m3,184607 524.4%   
Net fx Rs m1,219357 341.4%   
CASH FLOW
From Operations Rs m2,4371,345 181.2%  
From Investments Rs m-6,265-2,256 277.7%  
From Financial Activity Rs m2,490-1,200 -207.5%  
Net Cashflow Rs m-1,337-2,111 63.4%  

Share Holding

Indian Promoters % 82.7 4.5 1,825.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.3 0.0 -  
FIIs % 5.5 1.4 407.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 94.1 8.0%  
Shareholders   10,665 20,807 51.3%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   PIRAMAL ENTERPRISES  GSK PHARMA  PANACEA BIOTECH  DR. REDDYS LAB  NOVARTIS  

Compare PLETHICO PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Strong; Consumer Durables Stocks Drag(01:30 pm)

After opening the day in green, share markets in India have continued the momentum and are trading above the dotted line. Except stocks in the consumer durables sector.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA 8-QTR ANALYSIS

COMPARE PLETHICO PHARMA WITH

MARKET STATS